Literature DB >> 10590106

E1B 55-kilodalton oncoproteins of adenovirus types 5 and 12 inactivate and relocalize p53, but not p51 or p73, and cooperate with E4orf6 proteins to destabilize p53.

S Wienzek1, J Roth, M Dobbelstein.   

Abstract

The p53 tumor suppressor protein represents a target for viral and cellular oncoproteins, including adenovirus gene products. Recently, it was discovered that several proteins with structural and functional homologies to p53 exist in human cells. Two of them were termed p51 and p73. We have shown previously that the E1B 55-kDa protein (E1B-55 kDa) of adenovirus type 5 (Ad5) binds and inactivates p53 but not p73. Further, p53 is rapidly degraded in the presence of E1B-55 kDa and the E4orf6 protein of this virus. Here, it is demonstrated that p51 does not detectably associate with E1B-55 kDa. While p53 is relocalized to the cytoplasm by E1B-55 kDa, p51's location is unaffected. Finally, p51 retains its full transcriptional activity in the presence of E1B-55 kDa. Apparently, p51 does not represent a target of Ad5 E1B-55 kDa, suggesting that the functions of p51 are distinct from p53-like tumor suppression. E1B-55 kDa from highly oncogenic adenovirus type 12 (Ad12) was previously shown to surpass the oncogenic activity of Ad5 E1B-55 kDa in various assay systems, raising the possibility that Ad12 E1B-55 kDa might target a broader range of p53-like proteins. However, we show here that Ad12 E1B-55 kDa also inhibits p53's transcriptional activity without measurably affecting p73 or p51. Moderate inhibition of p51's transcriptional activity was observed in the presence of the E4orf6 proteins from Ad5 and Ad12. p53 and Ad12-E1B-55 kDa colocalize in the nucleus and also in cytoplasmic clusters when transiently coexpressed. Finally, E1B-55 kDa and E4orf6 of Ad12 mediate rapid degradation of p53 with an efficiency comparable to that of the Ad5 proteins in human and rodent cells. Our results suggest that E1B-55 kDa of either virus type has similar effects on p53 but does not affect p73 and p51.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10590106      PMCID: PMC111528          DOI: 10.1128/jvi.74.1.193-202.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  60 in total

1.  p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development.

Authors:  A Yang; R Schweitzer; D Sun; M Kaghad; N Walker; R T Bronson; C Tabin; A Sharpe; D Caput; C Crum; F McKeon
Journal:  Nature       Date:  1999-04-22       Impact factor: 49.962

2.  Cancer. p53, guardian of the genome.

Authors:  D P Lane
Journal:  Nature       Date:  1992-07-02       Impact factor: 49.962

3.  Differential transcriptional activation by Oct-1 and Oct-2: interdependent activation domains induce Oct-2 phosphorylation.

Authors:  M Tanaka; W Herr
Journal:  Cell       Date:  1990-02-09       Impact factor: 41.582

4.  Role of adenovirus types 5 and 12 early region 1b tumor antigens in oncogenic transformation.

Authors:  R Bernards; P I Schrier; J L Bos; A J Van der Eb
Journal:  Virology       Date:  1983-05       Impact factor: 3.616

5.  A monoclonal antibody detecting the adenovirus type 5-E1b-58Kd tumor antigen: characterization of the E1b-58Kd tumor antigen in adenovirus-infected and -transformed cells.

Authors:  P Sarnow; C A Sullivan; A J Levine
Journal:  Virology       Date:  1982-07-30       Impact factor: 3.616

6.  Association of human papillomavirus types 16 and 18 E6 proteins with p53.

Authors:  B A Werness; A J Levine; P M Howley
Journal:  Science       Date:  1990-04-06       Impact factor: 47.728

7.  Adenovirus early region 1B 58,000-dalton tumor antigen is physically associated with an early region 4 25,000-dalton protein in productively infected cells.

Authors:  P Sarnow; P Hearing; C W Anderson; D N Halbert; T Shenk; A J Levine
Journal:  J Virol       Date:  1984-03       Impact factor: 5.103

8.  Localization of the E1B proteins of adenovirus 5 in transformed cells, as revealed by interaction with monoclonal antibodies.

Authors:  A Zantema; J A Fransen; A Davis-Olivier; F C Ramaekers; G P Vooijs; B DeLeys; A J Van der Eb
Journal:  Virology       Date:  1985-04-15       Impact factor: 3.616

9.  The intracellular distribution of the transformation-associated protein p53 in adenovirus-transformed rodent cells.

Authors:  M E Blair Zajdel; G E Blair
Journal:  Oncogene       Date:  1988-06       Impact factor: 9.867

10.  Adenovirus serotype determines association and localization of the large E1B tumor antigen with cellular tumor antigen p53 in transformed cells.

Authors:  A Zantema; P I Schrier; A Davis-Olivier; T van Laar; R T Vaessen; A J van der EB
Journal:  Mol Cell Biol       Date:  1985-11       Impact factor: 4.272

View more
  26 in total

1.  Effects of mutations in the adenoviral E1B 55-kilodalton protein coding sequence on viral late mRNA metabolism.

Authors:  Ramon A Gonzalez; S J Flint
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

2.  E1B-55-kilodalton protein is not required to block p53-induced transcription during adenovirus infection.

Authors:  Urs Hobom; Matthias Dobbelstein
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

3.  The E4orf6/E1B55K E3 ubiquitin ligase complexes of human adenoviruses exhibit heterogeneity in composition and substrate specificity.

Authors:  Chi Ying Cheng; Timra Gilson; Frédéric Dallaire; Gary Ketner; Philip E Branton; Paola Blanchette
Journal:  J Virol       Date:  2010-11-10       Impact factor: 5.103

4.  The adenovirus E1b55K/E4orf6 complex induces degradation of the Bloom helicase during infection.

Authors:  Nicole I Orazio; Colleen M Naeger; Jan Karlseder; Matthew D Weitzman
Journal:  J Virol       Date:  2010-12-01       Impact factor: 5.103

5.  Distinct requirements of adenovirus E1b55K protein for degradation of cellular substrates.

Authors:  Rachel A Schwartz; Seema S Lakdawala; Heather D Eshleman; Matthew R Russell; Christian T Carson; Matthew D Weitzman
Journal:  J Virol       Date:  2008-07-09       Impact factor: 5.103

6.  Role of E1B55K in E4orf6/E1B55K E3 ligase complexes formed by different human adenovirus serotypes.

Authors:  Chi Ying Cheng; Timra Gilson; Peter Wimmer; Sabrina Schreiner; Gary Ketner; Thomas Dobner; Philip E Branton; Paola Blanchette
Journal:  J Virol       Date:  2013-03-27       Impact factor: 5.103

7.  Aggresome formation by the adenoviral protein E1B55K is not conserved among adenovirus species and is not required for efficient degradation of nuclear substrates.

Authors:  Paola Blanchette; Peter Wimmer; Frédéric Dallaire; Chi Ying Cheng; Philip E Branton
Journal:  J Virol       Date:  2013-02-13       Impact factor: 5.103

8.  Tissue-specific, tumor-selective, replication-competent adenovirus vector for cancer gene therapy.

Authors:  K Doronin; M Kuppuswamy; K Toth; A E Tollefson; P Krajcsi; V Krougliak; W S Wold
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

9.  Using the E4orf6-Based E3 Ubiquitin Ligase as a Tool To Analyze the Evolution of Adenoviruses.

Authors:  Timra Gilson; Paola Blanchette; Mónika Z Ballmann; Tibor Papp; Judit J Pénzes; Mária Benkő; Balázs Harrach; Philip E Branton
Journal:  J Virol       Date:  2016-07-27       Impact factor: 5.103

10.  Adenovirus exploits the cellular aggresome response to accelerate inactivation of the MRN complex.

Authors:  Yue Liu; Anna Shevchenko; Andrej Shevchenko; Arnold J Berk
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.